We are live on ! Find out more
RNLX

Renalytix plc American Depositary Shares

Delisted

RNLX was delisted on the 7th of October, 2024.

41 hedge funds and large institutions have $184M invested in Renalytix plc American Depositary Shares in 2021 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 12 increasing their positions, 8 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 6

50% more repeat investments, than reductions

Existing positions increased: 12 | Existing positions reduced: 8

21% more capital invested

Capital invested by funds: $152M → $184M (+$31.3M)

8% more funds holding

Funds holding: 3841 (+3)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

5% less call options, than puts

Call options by funds: $1.77M | Put options by funds: $1.87M

Holders
41
Holders Change
+3
Holders Change %
+7.89%
% of All Funds
0.71%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
9
Increased
12
Reduced
8
Closed
6
Calls
$1.77M
Puts
$1.87M
Net Calls
-$100K
Net Calls Change
-$2.36M

RNLX Hedge Fund Activity: Q2 2021 in Review

41 of the 5,767 institutional investors tracked by Wall St. Rank reported a position in Renalytix plc American Depositary Shares (RNLX) for Q2 2021, worth a combined $184M — up 21% from $152M a quarter earlier.

Buyers outnumbered sellers: 9 funds opened new RNLX positions and 6 closed out — a net gain of 3 holders — while 12 added to existing stakes and 8 trimmed.

The largest buyer was Gilder Gagnon Howe & Co, adding an estimated $7.36M. The largest seller was Parian Global Management, cutting an estimated $9.57M.

  • 41 institutional investors held Renalytix plc American Depositary Shares (RNLX) as of Q2 2021, up from 38 in Q1 2021.
  • Funds reported $184M of Renalytix plc American Depositary Shares stock for Q2 2021, up 21% quarter-over-quarter.
  • 9 funds opened new Renalytix plc American Depositary Shares positions in Q2 2021 and 6 closed out, a net change of +3 holders.
  • The largest Renalytix plc American Depositary Shares buyer in Q2 2021 was Gilder Gagnon Howe & Co, an estimated $7.36M added.
  • The largest Renalytix plc American Depositary Shares seller in Q2 2021 was Parian Global Management, an estimated $9.57M sold.

Based on aggregated 13F filings for Q2 2021.